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1. INTRODUCTION
Annually, there are reports of deaths of 
around 2 million people in the world 
due to fungal infections (Brown et al., 
2012). Such ratio of death is even 
beyond the mortality rate of malaria 
(Vos et al., 2012). The most 
encountered and considered infections 
by a filamentous fungus are related to 
the Aspergillus fumigates (A. 
fumigatus) (Hospenthal, et al, 1998). It 
can cause life threatening invasion in 
patients. Vast majority of infections 
with Aspergillus fumigates  is ended up 
with death (Gupta et al, 2012). This is 
specifically in patients with immune 
system debility. Immune system may be 
debilitated due to many reasons, such as 
Acquired immunodeficiency Syndrome 
(AIDS), leukemia, transplantation, and 
chemotherapy receiving patients 
(Brown et al., 2012). The fungus has 
the ability to produce high rate of 
conidia. These spore structures are then 
spread through air into the environment 
(Filler and Sheppard, 2006). Human 
without noticing may inhale more than 
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      The filamentous fungus Aspergillus fumigatus is the most 
considerable common opportunistic pathogen. This is due to the 
prevalence of its occurrence in patients with immune debilities. It 
can cause diseases with impact extends to life-threatening 
seriousness. This fungus recently showed interesting means of 
adaptation, biofilm formation, and morphogenesis within the host 
biome. Its ability to invade and systematically disperse in the 
patient’s body is of great concern. The complications of antifungal 
therapy and the limited target available to treat such infections, 
urge intensive and thorough research to uncover new more 
effective targets. The present study revealed a novel possibility of 
making the pptA an effective address in the fungus for antifungal 
treatment. Knocking-out the pptA gene resulted in halting 
pathogenecity as it correlated with essential genes of pathogenecity 
medA which showed considerable down regulation. Significant 
increase of protein profile has been discovered in ∆pptA strains as 
UBC gene highly activated and protein assay revealed high rate of 
production. In conclusion, the present study emphasize pptA as a 
possible strong antifungal target and declares high protein output 
from ∆pptA which may be a promised strain for industrial and 
beneficial protein production. 
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hundred of these spores a day while 
breathing, specifically in areas 
contaminated with such conidia. These 
small tiny structures can easily 
penetrate the air passages into the 
alveoli of the lung (Chandrasekar et al, 
2000). However, in normal 
circumstances as the body defense 
system working, it can wipe out these 
spores through the innate and acquired 
immune army. Nevertheless, for 
patients who suffer immune system 
debility or suppression the presence of 
those spores are problematic, as failure 
to eradicate those conidia may 
eventually lead to germination and 
growth of the Aspergillus fumigatus  
(Ben-Ami et al, 2010). This can cause 
tissue invasion and aspergillosis may 
arise. Aspergillosis is one of the most 
infective life threatening diseases in 
those patients.  The germination and 
growth of the fungus inside the human 
host are mostly dependent on the 
proteins and metabolic activities of the 
fungus. These pathways of 
pathogenecity and invasiveness are 
based on the active gene expression of 
the fungus to survive and nourish in 
such a complex new environment 
(Dagenais and Keller, 2009). The onset 
of the infection and success of the 
pathogen are of many types. Patients 
with previous history of asthma or 
fibrosis can show allergic response 
known as Allergic Brnonchopulmonary 
Aspergillosis (ABPA). Also fungal 
sensitization may occur in asthma 
patients. Coughing, sneezing, running 
nose, and hay fever like symptoms may 
appear. The success of germination may 
cause long persistence of the fungi in 
the chest known as Chronic Pulmonary 
Aspergillosis (CPA). Patients with 
underlying lung diseases such as 
tuberculosis are more prone to such 
infection and complications. 
Aspergillus can grow in pre-existing 
cavities of the lung and form a ball like 
structure of hyphae known as (Fungus 
Ball) (Denning et al, 2009).The fungus 
ball in addition to the mycelia it may 
contain necrotic tissues, mucus and 
immune responded cells. Patients may 
suffer from fatigue, muscle pain, long 
term coughing and difficulty of breath. 
The most dangerous and life-
threatenting type of infection is 
invasive aspergillosis (IA). Invasive 
aspergillosis is of a great medical 
concern as it can cause high mortality 
rate in patients with critically ill 
conditions in addition to the 
immunocompromised individuals 
(Denning et al, 2003). None specific 
symptoms may appear such as fever, 
pain of the chest and production of 
mucus sputum. Treatment of fungal 
infections and especially aspergillosis, 
so far, has not succeeded in limitation 
of the high mortality rate (Kousha et al, 
2011). The invasive systematic 
infections by Aspergillus fumigatus and 
other fungi require systematic 
interference with highly affective 
antifungal (Walsh et al, 2004). This is 
in order to deliver the drug to the 
targeted area in deep tissue infections. 
Intravenous and oral administrations of 
systematic antifungal are used widely 
nowadays in order to eradicate the 
infection. However, the emergence of 
antifungal resistance and the lack of 
variety of targets declined the success 
possibilities of cure. In addition, the 
fate of the antifungal and their 
biochemical activity in the tissues also 
has been of medical mycology concern 
(Denning and Bromley, 2015). 
Consequently, researches are ongoing 
toward the discovery of new antifungal 
targets with more potential treatment 
bioactivity. Billions of dollars annually 
been spent for the available antifungals 
in the market. These are includes 
echinocandins, azoles, polyenes and 
pyrimidine analogues, but however the 
death rate are still high. These classes 
have fenced ability to attack fungal cell 
rather than chitin and sterols (Denning 
and Hope, 2010). Thus, finding a new 
target for antifungals with high 
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specificity, vital essentiality and 
accessible feature is a goal of the 
present study. The target, however, 
should be crucial for biological activity 
of the pathogen. The 
Phosphopantetheinyl transferases 
(PPTase)  is shown to be a fundamental 
metabolite in many bacteria as well as 
plant fungal pathogens (Walsh et al, 
1997). With little investigation of this 
imperative target in human pathogens, 
the current study shed lights on the 
metabolites and protein profiles of pptA 
gene and its possibility to be an 
antifungal target. Phosphopantetheinyl 
transferases (PPTase) is a necessary 
enzyme for the adjustment of many 
other proteins after translation such as 
polyketide synthases, nonribosomal 
peptide syntheases, and fatty acid 
synthases. 
 
2. MATERIALS AND METHODS: 
 
2.1. Growth of fungus 
 
The  ATCC3626 strain of Aspergillus 
fumigatus used to be grwon under 
standard condition on Potato Dextrose 
Agar PDA (Temperature: 24°C to 26°C 
Atmosphere: Typical aerobic). 
 
2.2. DNA Extraction: 
Slightly tuned and optimized Cetyl 
Trimethyl Ammonium Bromide 
(CTAB) method for DNA extraction 
was used as described by Fraczek et al 
2013. Where spores were collected 
using surface wash out with 
PBS/Tween20 and centrifuged at 14000 
rpm for about 2 minutes. The sediment 
was then added for a suspension of the 
extraction buffer of CTAB. The 
sediment then added to a 2mL screw 
capped tubes that previously filled up to 
300µL with sterile glass beads. 
Respective three cycles of vortexing 
were then applied intervened by 10 
minutes incubation of the tubes at 60˚C. 
The tubes then left for rest at room 
temperature 5 minutes and centrifuged 
later at 1400 rpm for 5 minutes. 
Amount of 700µL of the supernatant 
transferred to sterile 2mL tubes and 
4µL of RNase (Qiagen) to be added. 
The tubes were incubated at 37˚C for 
about 10 minutes. Using 25:1 
chloroform:isoamyl alcohol to eliminate 
any protein content, amount of 700µL 
and mix by vortexing for 10 seconds 
only. Centrifugation of the tubes then 
performed with 1400 rpm for 2 minutes. 
An amount of 600µL of the supernatant 
then added to a set of new sterile 1.5mL 
tubes. Isopropanol was added to the 
tubes and mixed manually by inverting 
the tubes up and down. Another round 
of centrifugation for 5 minutes at 14000 
rpm was performed and the supernatant 
discarded. Ethanol with 70% 
concentration were added (500µL) and 
vortexed for only 5 seconds in order to 
wash the sediment from any debris and 
proteins. The mixture centrifuged again  
at 9000 rpm for 2 minutes. The ethanol 
supernatant removed  and the pellet let 
to dry at room temperature. DNA were 
harvested by adding 100µL of 
molecular grade dH2O. 
2.3. Primers: 
The primers were designed, optimized 
and efficiency test performed. Table 2.1 
shows the list of primers used in the 
present study. 
























medA and UBC are designed specifically 
for this study. 
 
2.4 Generation of Knockouts in A. 
fumigatus: 
 
The methodology for generating a 
knockout strain of A. fumigatus through 
PCR fusion along with transformation 
of the fungus has been well addressed 






Figure 1: A: The fusion PCR 
technique for knocking out the gene 
of interest (adapted from Szewczyk et 
al., 2006). Both flank ends along with 
a selected marker were amplified in 
the first round of PCR reaction. The 
second round included nested 
primers P5 and P6 to increase the 
precision of product amplification.  
B: Generation of knowckout 
sequence after 2 cycles of fusion pcr 
resulted in 4kb DNA sequence.  
 
2.5. Growth rate determination: 
The growth rate of both radial on agar 
and in broth were determined using 
Vogel`s Minimal Media (VMM). 
However in order to harmonize the 
growth rate of both knockout and 
parental strains, 0.5 mM FeSO4 or 10 
mM lysine or both 0.5 mM FeSO4 and 
10 mM lysine has been added (Fraczek 
et al 2013). 
 
2.6. The Bradford (Coomassie) protein 
production assay: 
The amount of 2x10
6 
harvested spores 
of knockout strain and parental strain of 
A. fumigates of were added to 250 ml 
broth VMM in flasks. The negative 
control was established as media only. 
The samples were each of 5 replicates. 
Shaker incubator was used at 200 rpm. 
From the supernatant of the growth 
medium, one millilitre were taken and 
sterilized by filtration using Whatman 
#2 filter paper. The Bradford assay 
(Coomassie) protein detection kit were 
used (thermo scientific). The protein 
5Kb ladder DNA 
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estimation were performed as per the 
manufacturer protocol. The replicates 
of samples were added to microplates 
and their absorbance were determined 
using scanning spectrophotometer (Bio 
TEK Synergy). A T-Test used to 
indicate significance of protein 
production. 
2.7. Real- Time PCR: 
Gene expression for the knockout strain 
along with parental strains was 
compared by using the development 
modification gene medA gene along 
with the ubiquitin C UBC in both. The 
gene expression rates were determined 
using the real-time PCR (BIO-RAD). 
The data were analysed using 
REST2000 program. 
 
2.8. Statistical Analysis: 
The T-test paired group analysis were 
used to determine difference between 
parental (WT) and knockout (KO) 
strain of A. fumigatus. Prism graphpad 
were used to present the data and 
calculate correlations. REST2000 
program were used to analyse data of 
the real-time PCR.  
Results and Discussion: 
The present study aimed to generate a 
knock-out strain of A. fumigatus that 
lacks the pptA gene. This is as a novel 
step toward finding new targets for the 
antifungal used against this filamentous 
invasive fungus. The results showed 
interesting approaches when parental 
wild type compared to the knockout 
strain. The growth rate and the protein 
profile showed promising results toward 
further investigation into this essential 
gene and seeking vital antifungal target. 
Generation of the knockout strain 
successfully performed (Figure 2) and 
the strain showed effective growth on 
media supplemented with nutrients such 
as FeSO4 and Lysin (Figure 3). 
 
Figure 2: The two tested strains of 
parental (A) and the ∆pptA (B). 
 
 
Figure 3: Growth rate determined 
through radial growth diameter 
determination of both parental strain 
(A) and the knockout strain (B).  The 
knockout strain was supplemented 
with 1.5 mM FeSO4 and 10 mM 
lysine. 
Growth on broth medium were also 
determined and tuned in order to get the 
optimal equal growth of both strains. 
However providing 1.5 mM FeSO4 and 
10 mM lysine were also necessary for 
the growth of the knockout in broth 
medium to come in parallel with the 
wild type strain (Figure 4) 
 
Figure 4: Growth rate determined 
through optical density 
determination of both parental strain 
(WT) and the knockout strain (KO).  
The knockout strain was 
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supplemented with 1.5 mM FeSO4 
and 10 mM lysine. 
This indicated that the deletion of the 
pptA gene urges the fungi for the need 
of lysine and ferrous. Thus essentiality 
of the pptA for functions related to the 
cellular virulence as ferrous is strongly 
needed to activate set of genes that have 
crucial role in adaptation, ergosterol 
biosynthesis, and drug resistance (Haas, 
2012). Lysine was shown to be a 
possible antifungal target. Depletion of 
lysine resulted in activated lysine 
uptake by the fungus (Schöbel et al, 
2010). The result of this study shows 
possibility of targeting pptA products to 
starve the fungal cell from both iron and 
lysine. 
The protein production assay for both 
strains showed interesting profile for 
the knockout. Compensation of the 
depleted and deleted enzymes results in 
the high production of various proteins 
(Figure 5). The results of the present 
study showed significant increase of 
protein production profile of the 
knockout strain, specifically when the 
media supplemented with 1% of 
Carboxymethyle cellulose   (CMC) and 
1% Glycerol.  
 
Figure 5: Bradford (Coomassie) 
protein assay. The total protein 
outputs of the knockout strain have 
been increased significantly by time. 
Increase of the protein production is a 
promising approach toward further 
study of the pptA mutant. Seeking 
essential proteins and their reliability on 
each other is a considerable concern. 
The protein production tested for the 
knockout strain through a CMC 
contained medium. It turned out that the 
knockout strain have the ability to 
assimilate cellulose effectively and 




Figure 6: Growth on CMC contained 
medium showed significant radial 
progress of the knockout strain (A) in 
compare to the parental strain (B). 
The statistical analysis showed 
significant differences of the 
percentage of clearance of cellulose 
(C).   
From the protein production assay and 
the growth characteristics, the study 
showed that the knockout strain can 
present high protein yield. This is in 
order to compensate the secondary 
metabolites that will be missing when 
the gene is disrupted, indicating the 
essentiality and crucial role of the pptA 
gene in the fungal growth and 
progression. The new protein profile 
can also provide closer insight for the 
ability of the organism to produce some 
new industrial proteins that can be 
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harvested. Cellulose assimilation test 
indicated high rate of cellulase enzyme 
providing a promising approach toward 
the capability of the fungi to be directed 
for industrial production of cellulase 
enzyme.  
Results of gene expression and 
transcription profile for selected genes 
of pathogenecity and ubiquitin protein 
activity have revealed an interesting up-
regulation of the genes when pptA has 
been knocked out in compare with the 
parental strains. Table 2 shows the real 
time PCR interpretation result. The 
medA gene was down-regulated by 3 
folds while UBC is actively expressed 
with 10 folds expression increase. 
The medA gene is shown to have a 
great role in pathogenecity and 
adaptation of A. fumigatus. It has roles 
in morphogenesis and hyphal growth. 
Recently the gene is indicated a high 
efficiency in fungus ball formation and 
biofilm triggering (Busby et al., 1996, 
Yu et al., 2006). In a comprehensive 
study of Twumasi-Boateng and others 
(2009), medA shown to be one of the 
most effective genes contributed to 
virulence. 
Table 2: The real time PCR results of 
gene expression for transcription profile 
of selected genes. 
Gene Type Reaction 
Efficiency 
Express P Result 
medA TRG 0.99 3.077 0.014 Down 
UBC TRG 0.99 10.76 0.012 UP 
Interpretation 
medA is UP-regulated in sample 
group (in comparison to control 
group) by a mean factor of 3.077 
(S.E. range is 1.27 – 1.32). 
UBC is UP-regulated in sample 
group (in comparison to control 
group) by a mean factor of 
10.766 (S.E. range is 1.73 - 
1.88). 
 
Thus, the down-regulation of medA in 
∆pptA indicates correlation of the gene 
with the pathogenecity, which 
eventually present it as a promising 
novel antifungal target. On the other 
hand, UBC up-regulation may reveal 
the response of the cell toward high 
protein production profile as indicated 
in the present study when pptA is 
knocked out. 
 
Figure 7: The transcriptomic profile 
of the selected genes expression levels 
of both wild type (WT) and knockout 
strains (KO) in a mixed biofilm. 
    
The UBC is shown to play a role in 
pathogenecity and virulence of A. 
fumigatus as an important step of 
successful adhesion and initiation of 
disease related to endothelial response 
of the host (Richie et al., 2011). Also in 
other studies has been used as 
housekeeping gene for gene expression 
studies (Ren et al., 2010). ). In fact 
protein elimination and cellular protein 
level regulation are robust functions of 
the UBC (Shankar et al., 2005). The 
current findings of this study showed 
interesting response of UBC gene 
expression when protein levels is 
increasing. This correlating the high 
rate of protein with gene expression 
changes in the knockout strain of the 
pathogenic A. fumigatus. Nevertheless, 
such a high input of proteins may pave 
the way toward finding new antifungal 
targets as well as beneficial proteins and 
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In conclusion, the present study showed 
that the gene pptA is strongly related to 
pathogenecity of A. fumigatus. This is 
in addition to its vital role in essential 
cellular mechanisms of growth and 
protein production control. The deletion 
of this gene could reveal a new protein 
profile of which further study is crucial 
to identify the possibility of industrial 
and production harvest of those 
proteins. 
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